论文部分内容阅读
目的:探索米索前列醇对预防产后出血的临床效果。方法:采用回顾的形式分析本医院2013年9月至2014年3月这半年来49例足月且自然分娩的患者,将49例患者随机分为两组,对照组24人,实验组25人。实验组的患者在自然分娩后服用米索前列醇片,对照组患者在自然分娩后注射缩宫素,一次测定实验组和对照组产妇的出血量,第三产程时间[1],产后出血发生率及产妇血压等。结果:实验组的第三产程时间比对照组短,产后2h的出血量以及产后出血发生率实验组均比对照组低,两组之间存在差异性,有可比性。讨论:米索前列醇能促进子宫的收缩,其作用比缩宫素强,服用米索前列醇能有效的缩短第三产程时间,减少产后出血。
Objective: To explore the clinical effect of misoprostol in preventing postpartum hemorrhage. Methods: A retrospective analysis of our hospital in September 2013 to March 2014 49 cases of full-term and natural childbirth, 49 patients were randomly divided into two groups, the control group of 24 people, the experimental group of 25 people . Patients in the experimental group took misoprostol tablets after spontaneous delivery, and patients in the control group received oxytocin after spontaneous delivery. The amount of bleeding, the third stage of labor and the postpartum hemorrhage were measured in the experimental group and the control group [1] Rate and maternal blood pressure and so on. Results: The duration of the third stage of labor in the experimental group was shorter than that in the control group. The amount of bleeding at 2h postpartum and the incidence of postpartum hemorrhage in the experimental group were lower than those in the control group. There were differences and comparability between the two groups. Discussion: Misoprostol can promote uterine contraction, its role than oxytocin, take misoprostol can effectively shorten the third stage of labor time, reduce postpartum hemorrhage.